THE EFFECTIVENESS OF ALLOGENEIC LEUKOCYTE IMMUNIZATION IN UNEXPLAINED PRIMARY RECURRENT SPONTANEOUS-ABORTION

被引：89

作者：

DAYA, S ^{[1
]}

GUNBY, J ^{[1
]}

AOKI, K ^{[1
]}

CARP, HJA ^{[1
]}

CAUCHI, MN ^{[1
]}

LIM, D ^{[1
]}

CHRISTIANSEN, OB ^{[1
]}

GRUNNET, N ^{[1
]}

COWCHOCK, S ^{[1
]}

SMITH, JB ^{[1
]}

GATENBY, P ^{[1
]}

CAMERON, K ^{[1
]}

GILL, TJ ^{[1
]}

HO, HN ^{[1
]}

GEORGIEVA, R ^{[1
]}

BELCHEV, D ^{[1
]}

KILPATRICK, DC ^{[1
]}

LISTON, W ^{[1
]}

MOWBRAY, JF ^{[1
]}

UNDERWOOD, J ^{[1
]}

PARAZZINI, F ^{[1
]}

CROSIGNANI, PG ^{[1
]}

REZENKOFF, MF ^{[1
]}

SAJI, F ^{[1
]}

KOYAMA, M ^{[1
]}

机构：

[1] MCMASTER UNIV, DEPT CLIN EPIDEMIOL & BIOSTAT, HAMILTON, ON, CANADA

来源：

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 1994年 / 32卷 / 04期

关键词：

RECURRENT SPONTANEOUS ABORTION; IMMUNOTHERAPY; LEUKOCYTE IMMUNIZATION; METAANALYSIS;

D O I：

10.1111/j.1600-0897.1994.tb01129.x

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

PROBLEM: Unexplained primary recurrent spontaneous abortion (RSA) can be viewed as a partner-specific problem for which immunization with allogeneic leukocytes is being offered as therapy. Published data from randomized controlled trials have produced conflicting results regarding treatment effectiveness. The aim of this study was to perform a subgroup analysis of the data from a recent worldwide collaborative meta-analysis using the raw data for patients with primary RSA entered into randomized controlled trials of immunotherapy. METHODS: Data from randomized controlled trials in eight centers were included in this analysis. Individual patients were included only if they had had three or more spontaneous abortions, no previous pregnancy beyond 20 weeks' gestation, no identifiable cause for the abortions, and no evidence of antipaternal antibodies. Meta-analysis by centre and logistic regression analysis were performed to determine the overall effect of treatment in achieving live birth and to identify variables that affect the prognosis for a successful outcome. RESULTS: In the meta-analysis by center, immunotherapy significantly improved the live birth rate (common odds ratio = 1.94, 95% confidence interval (CI) = 1.20 to 3.12). In the analysis by patient, the likelihood of a successful outcome was also significantly better with treatment (relative risk = 1.46, 95% CI 1.19 to 1.69). The absolute treatment effect was 16.3% producing a number needed to treat of 6. The number of previous abortions had a significant negative correlation with live birth rate, such that for each additional pregnancy loss beyond three, the likelihood of live birth was reduced by 23%. CONCLUSION: Allogeneic leukocyte immunization is an effective treatment for unexplained primary RSA when pretreatment antipaternal antibodies are absent. Better diagnostic tests are required to identify patients who may derive maximal benefit from this therapeutic approach.

引用

页码：294 / 302

页数：9

共 23 条

[1]

[Anonymous], 1982, Lancet, V2, P1173

[2]

AOKI K, 1994, AM J REPROD IMMUNOL, V32, P55

[3]

Canadian Cooperative Study Group, 1978, N Engl J Med, V299, P53

[4] TREATMENT OF RECURRENT ABORTERS BY IMMUNIZATION WITH PATERNAL CELLS - CONTROLLED TRIAL [J].

CAUCHI, MN ;

LIM, D ;

YOUNG, DE ;

KLOSS, M ;

PEPPERELL, RJ .

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1991, 25 (01) :16-17

[5]

Chaouat G., 1988, EARLY PREGNANCY LOSS, P89

[6] DECIDUA-ASSOCIATED SUPPRESSOR ACTIVITY AND VIABILITY OF INDIVIDUAL IMPLANTATION SITES OF ALLOPREGNANT C3H MICE [J].

CLARK, DA ;

DRAKE, B ;

HEAD, JR ;

STEDRONSKACLARK, J ;

BANWATT, D .

JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1990, 17 (03) :253-264

[7]

CLARK DA, 1991, CRIT REV IMMUNOL, V11, P215

[8] TRIALS AND TRIBULATION IN THE TREATMENT OF RECURRENT SPONTANEOUS-ABORTION [J].

CLARK, DA ;

DAYA, S .

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1991, 25 (01) :18-24

[9] PREVENTION OF SPONTANEOUS-ABORTION IN DBA/2-MATED CBA/J MICE BY GM-CSF INVOLVES CD8(+) T-CELL-DEPENDENT SUPPRESSION OF NATURAL EFFECTOR CELL CYTOTOXICITY AGAINST TROPHOBLAST TARGET-CELLS [J].

CLARK, DA ;

CHAOUAT, G ;

MOGIL, R ;

WEGMANN, TG .

CELLULAR IMMUNOLOGY, 1994, 154 (01) :143-152

[10] REPORT FROM THE ETHICS-COMMITTEE-FOR-IMMUNOTHERAPY [J].

COULAM, CB .

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1993, 30 (01) :45-47

← 1 2 3 →